MedTrace Logo

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

NCT01893892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-08-04

No results posted yet for this study

Summary

This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.

Conditions

  • Musculoskeletal Complications

Interventions

DIETARY_SUPPLEMENT

levocarnitine

Given PO

OTHER

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Anne Lynn Chang · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-03-15
Completion
2017-03-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893892 on ClinicalTrials.gov